Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test conversion after unprotected exposure to patients with pulmonary tuberculosis: 6-year experience in an Italian teaching hospital.

Muzzi A, Seminari E, Feletti T, Scudeller L, Marone P, Tinelli C, Minoli L, Marena C, Mangiarotti P, Strosselli M.

BMC Infect Dis. 2014 Jun 12;14:324. doi: 10.1186/1471-2334-14-324.

PMID:
24919953
[PubMed - in process]
Free PMC Article
2.

Allergic fungal rhinosinusitis due to Curvularia lunata.

Cavanna C, Seminari E, Pusateri A, Mangione F, Lallitto F, Esposto MC, Pagella F.

New Microbiol. 2014 Apr;37(2):241-5. Epub 2014 Apr 1.

PMID:
24858653
[PubMed - indexed for MEDLINE]
Free Article
3.

Tuberculosis-induced haemophagocytic syndrome in a patient on haemodialysis treated with anti-thymocyte globulin.

Seminari E, Contardi G, Rubert L, Fronti E, Comoli P, Minoli L, Zecca M.

Int J Tuberc Lung Dis. 2014 Feb;18(2):248-9. doi: 10.5588/ijtld.13.0533. No abstract available.

PMID:
24429321
[PubMed - in process]
4.

Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting.

Brandolini M, Novati S, De Silvestri A, Tinelli C, Patruno SF, Ranieri R, Seminari E.

BMC Public Health. 2013 Oct 20;13:981. doi: 10.1186/1471-2458-13-981.

PMID:
24139133
[PubMed - in process]
Free PMC Article
5.

Differences in implementation of HIV/AIDS clinical research in developed versus developing world: an evidence-based review on protease inhibitor use among women and minorities.

Seminari E, De Silvestri A, Scudeller L, Scotti V, Tinelli C.

Int J STD AIDS. 2012 Dec;23(12):837-42. doi: 10.1258/ijsa.2012.012047. Review.

PMID:
23258820
[PubMed - indexed for MEDLINE]
6.

Colitis in an elderly immunocompetent patient.

Seminari E, Fronti E, Contardi G, Broglia F, Scevola D, Fiorina L, Baldanti F.

J Clin Virol. 2012 Nov;55(3):187-90. doi: 10.1016/j.jcv.2012.06.007. Epub 2012 Jul 10. No abstract available.

PMID:
22784437
[PubMed - indexed for MEDLINE]
7.

Response to antiretroviral treatment after failure of NNRTI plus NRTIs-based therapy. Data from the ARCA collaborative group.

Seminari E, De Silvestri A, Meini G, Callegaro A, Boeri E, Punzi G, Gianotti N, Bruzzone B, Tinelli C, Grossi P.

Curr HIV Res. 2012 Jun;10(4):334-40.

PMID:
22591356
[PubMed - indexed for MEDLINE]
8.

Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.

Castagna A, Galli L, Torti C, D'Arminio Monforte A, Mussini C, Antinori A, Cozzi-Lepri A, Ladisa N, De Luca A, Seminari E, Gianotti N, Lazzarin A.

Antivir Ther. 2010;15(2):165-75. doi: 10.3851/IMP1513.

PMID:
20386071
[PubMed - indexed for MEDLINE]
9.

Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.

Seminari E, Tinelli C, Ravasi G, Ripamonti D, Ladisa N, Marino N, Sighinolfi L, Mondello P, Migliorino M, Carosi G, Maserati R; MASTER Cohort.

Curr HIV Res. 2010 Apr;8(3):186-93.

PMID:
20163342
[PubMed - indexed for MEDLINE]
10.

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial.

Soria A, Danise A, Galli L, Tiberi S, Seminari E, Cossarini F, Bigoloni A, Marcotullio S, Lazzarin A, Castagna A.

J Clin Virol. 2010 Mar;47(3):253-7. doi: 10.1016/j.jcv.2009.12.007. Epub 2010 Jan 6.

PMID:
20056480
[PubMed - indexed for MEDLINE]
11.

Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.

Saracino A, Monno L, Tartaglia A, Tinelli C, Seminari E, Maggiolo F, Bonora S, Rusconi S, Micheli V, Lo Caputo S, Lazzaroni L, Ferrara S, Ladisa N, Nasta P, Parruti G, Bellagamba R, Forbici F, Angarano G.

Curr HIV Res. 2009 Jul;7(4):425-33.

PMID:
19601778
[PubMed - indexed for MEDLINE]
12.

Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients.

Spagnuolo V, Gianotti N, Seminari E, Galli L, Fusetti G, Salpietro S, Lazzarin A, Castagna A.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):192-5. doi: 10.1097/QAI.0b013e31819367fc.

PMID:
19131889
[PubMed - indexed for MEDLINE]
13.

CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.

Seminari E, De Silvestri A, Boschi A, Tinelli C.

AIDS Rev. 2008 Oct-Dec;10(4):236-44.

PMID:
19092979
[PubMed - indexed for MEDLINE]
14.

Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection.

Montaner J, Yeni P, Clumeck NN, Fätkenheuer G, Gatell J, Hay P, Seminari E, Peeters MP, Schöller-Gyüre M, Simonts M, Woodfall B; TMC125-C203 Study Group.

Clin Infect Dis. 2008 Oct 1;47(7):969-78. doi: 10.1086/591705.

PMID:
18764771
[PubMed - indexed for MEDLINE]
Free Article
15.

Etravirine for the treatment of HIV infection.

Seminari E, Castagna A, Lazzarin A.

Expert Rev Anti Infect Ther. 2008 Aug;6(4):427-33. doi: 10.1586/14787210.6.4.427. Review.

PMID:
18662109
[PubMed - indexed for MEDLINE]
16.

Haemostatic activation in HIV infected patients treated with different antiretroviral regimens.

Pan A, Testa S, Quiros Roldan E, Tinelli C, Bodini U, Cadeo B, Carnevale G, Martinelli I, Maserati R, Morstabilini P, Seminari E, Signorini L, Carosi G.

Curr HIV Res. 2008 Jan;6(1):70-6.

PMID:
18288978
[PubMed - indexed for MEDLINE]
17.

Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levels.

Spagnuolo V, Gentilini G, De Bona A, Galli L, Uberti-Foppa C, Soldarini A, Dorigatti F, Seminari E.

New Microbiol. 2007 Jul;30(3):279-82.

PMID:
17802909
[PubMed - indexed for MEDLINE]
Free Article
18.

Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment.

Seminari E, De Bona A, Gentilini G, Galli L, Schira G, Gianotti N, Uberti-Foppa C, Soldarini A, Dorigatti F, Lazzarin A, Castagna A.

J Antimicrob Chemother. 2007 Oct;60(4):831-6. Epub 2007 Aug 7.

PMID:
17684056
[PubMed - indexed for MEDLINE]
Free Article
19.

Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.

Seminari E, Gentilini G, Galli L, Hasson H, Danise A, Carini E, Dorigatti F, Soldarini A, Lazzarin A, Castagna A.

J Antimicrob Chemother. 2005 Oct;56(4):790-2. Epub 2005 Sep 5.

PMID:
16143711
[PubMed - indexed for MEDLINE]
Free Article
20.

Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients.

Seminari E, Guffanti M, Villani P, Gianotti N, Cusato M, Fusetti G, Galli A, Castagna A, Regazzi M, Lazzarin A.

Eur J Clin Pharmacol. 2005 Aug;61(7):545-9. Epub 2005 Jul 23.

PMID:
16041598
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk